Harvard Bioscience Sets 10-for-1 Reverse Split Effective March 13 to Boost Share Price
Harvard Bioscience will implement a 10-for-1 reverse stock split on March 13, 2026, to raise its per-share price and comply with Nasdaq’s minimum $1 bid requirement. The company’s stock trading at $0.55 and market cap of $24.6M underscores its need to enhance market presence.
1. Reverse Stock Split Implementation
Harvard Bioscience’s board and shareholders approved a 10-for-1 reverse stock split scheduled to take effect at 4:30 p.m. ET on March 13, 2026, consolidating every ten existing shares into one new share. The split ratio aims to raise the per-share trading price.
2. Stock Price and Market Capitalization
Prior to the split, shares traded between $0.54 and $0.57, closing at $0.55, with a market capitalization of approximately $24.6 million and daily volume of 313,998 shares. The stock’s 52-week range spans $0.28 to $0.95.
3. Nasdaq Listing Compliance
The reverse split is designed to help the company meet Nasdaq’s minimum $1.00 bid price requirement, ensuring continued listing and avoiding potential delisting procedures.
4. Post-Split Trading Schedule
Trading of the newly adjusted shares will commence on the market open of March 16, 2026, allowing investors to trade based on the adjusted share count and price.